Golden Blue, a leading whiskey producer in South Korea, said that the Carlsberg Group canceled their contract, but it was a one-sided decision. The company said the move had left it with huge losses.
Golden Blue also distributes important alcoholic beverages in the country and on Tuesday, March 28, it said that the Danish brewing company "unilaterally" discontinued their agreement for the distribution and sale of its Carlsberg beer brand. It said that the contract had been invalidated earlier this month.
According to The Korea Herald, Golden Blue announced that it will now stop the sale of the Carlsberg beer products starting Friday of this week. The company said that the notice of contract termination sent by the Denmark headquartered brewer to them was “tyrannous.”
Golden Blue described Carlsberg’s move in this way because the cancellation was decided upon by just one party when a contract is signed and agreed upon by two entities. The Korean brand of whisky products said they have been renewing contracts every year since 2018, but since last year, Carlsberg suddenly changed it to short-term contracts.
Golden Blue said that this move is an obvious attempt for the Danish beer brand to establish its own sales unit in the country. For this, it is planning to file a complaint with the Korean Fair Trade Commission. It also suggested that it could file a separate lawsuit to be compensated for losses incurred after Carlsberg changed the terms of their agreement.
“Despite various malicious rumors in the market and difficulties in the market stagnation, GoldenBlue continued to invest manpower and resources,” Korea News Plus quoted Golden Blue as saying in a statement. GoldenBlue has maintained distribution of Carlsberg without any supply gap in the market, even while taking huge losses.”
The company added, “GoldenBlue plans to inform this unfairness of the unilateral contract termination by visiting the Danish embassy, filing a complaint with the Fair-Trade Commission, and filing a legal lawsuit claiming compensation for losses.”


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
U.S. Stocks Rally to Record Highs as AI Rebound Fuels Holiday-Shortened Session
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Asian Stock Markets Trade Flat as Holiday Liquidity Thins and BOJ Minutes Watched
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Asian Markets Rise as AI Rally Caps 2025, Gold and Silver Hit Record Highs
China Industrial Profits Slump Signals Need for More Economic Stimulus
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Volatility
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Japan to Audit Brazil’s Beef System, Paving Way for Market Access
Russian Stocks End Lower as Energy and Mining Shares Weigh on MOEX Index
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Asian Stocks and Gold Rally as Investors Chase Year-End Gains Amid Dollar Weakness 



